Genetic Engineering News: Gene Therapy for Crigler-Najjar Syndrome, a Rare Liver Disease, Shows Efficacy On August 21, 2023 / OPUS Clients in the News Read more →
Pharmaceutical Technology: UTMB and HDT Bio receive US funding for vaccine development On August 9, 2023 / OPUS Clients in the News Read more →
Genetic Engineering News: Généthon and Thales Collaborate on AI Tools for Gene Therapy On July 31, 2023 / OPUS Clients in the News Read more →
Clinical Trials Arena: HIghField Bio Initiates Its Glioma Trial with First Patient Dosing On July 17, 2023 / OPUS Clients in the News Read more →
Genetic Engineering News: Lifesaving Gene Therapies: Will They Reach Those Who Need Them Most? On June 8, 2023 / OPUS Clients in the News Read more →
Fierce Pharma: Atom Bioscience Hope to Make a Big Bang with New Gout Awareness Campaign On May 24, 2023 / OPUS Clients in the News Read more →
Genetic Engineering News: Cystic Fibrosis Foundation Funds Nanoparticle Delivery to Lung On March 15, 2023 / OPUS Clients in the News Read more →
Clinical Trials Arena: Atom Bioscience reports positive Phase IIa chronic gout therapy trial data On March 2, 2023 / OPUS Clients in the News Read more →
Genethon Newsletter No. 1 : 2023 On February 6, 2023 / OPUS Clients in the News, Uncategorized Read more →
Genetic Engineering News: Microalgal Vesicles Deliver Therapeutics to Protected Tissues On December 7, 2022 / OPUS Clients in the News Read more →
